March 24, 2026 · Form 4 insider transaction
Angel Matthew bought 231,482 shares of TEMPEST THERAPEUTICS INC at $2.16 per share, a transaction worth $500.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
The shares are held by Factor Bioscience Inc. ("Factor"). The Reporting Peron is the chief executive officer and chairman of the board of directors of Factor and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein.